A detailed history of Mayflower Financial Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Mayflower Financial Advisors, LLC holds 6,719 shares of NVO stock, worth $705,898. This represents 0.13% of its overall portfolio holdings.

Number of Shares
6,719
Previous 6,631 1.33%
Holding current value
$705,898
Previous $946,000 15.43%
% of portfolio
0.13%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$119.07 - $145.42 $10,478 - $12,796
88 Added 1.33%
6,719 $800,000
Q2 2024

Aug 02, 2024

BUY
$122.71 - $146.91 $298,921 - $357,872
2,436 Added 58.07%
6,631 $946,000
Q1 2024

Apr 29, 2024

BUY
$102.11 - $135.92 $193,906 - $258,112
1,899 Added 82.71%
4,195 $538,000
Q4 2023

Jan 22, 2024

BUY
$87.78 - $105.45 $6,144 - $7,381
70 Added 3.14%
2,296 $237,000
Q3 2023

Oct 12, 2023

BUY
$90.94 - $199.54 $202,432 - $444,176
2,226 New
2,226 $202,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mayflower Financial Advisors, LLC Portfolio

Follow Mayflower Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mayflower Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mayflower Financial Advisors, LLC with notifications on news.